Published in Clin Pharmacol Ther on October 12, 2011
Interferon induced IFIT family genes in host antiviral defense. Int J Biol Sci (2013) 1.13
Interferon-induced Ifit proteins: their role in viral pathogenesis. J Virol (2014) 1.07
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin. PLoS One (2012) 0.86
Glances in Immunology of HIV and HCV Infection. Adv Virol (2012) 0.82
Host genetic variants in the pathogenesis of hepatitis C. Viruses (2012) 0.82
Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis. Pharmacogenomics J (2015) 0.81
Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome. PLoS One (2014) 0.77
IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection. World J Gastroenterol (2016) 0.75
Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C. PLoS One (2017) 0.75
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol (1997) 4.08
Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 3.82
Randomised controlled trial of a short course of traditional acupuncture compared with usual care for persistent non-specific low back pain. BMJ (2006) 2.63
Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci U S A (1992) 2.30
Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Aliment Pharmacol Ther (2012) 2.25
Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. Health Technol Assess (2005) 2.21
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14
Infant mortality due to acute respiratory infections: the influence of primary care processes. Health Policy Plan (1997) 2.03
Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology (1995) 2.02
Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A (1996) 2.01
Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today (1998) 1.86
Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol (1994) 1.86
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology (1995) 1.84
Systematic review: hepatitis-associated aplastic anaemia--a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther (2009) 1.83
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol (2013) 1.74
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol (2000) 1.74
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients. Aliment Pharmacol Ther (2006) 1.74
Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst (2001) 1.72
Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med (1998) 1.70
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med (1994) 1.66
Tonsillectomy and inflammatory bowel disease location. Eur J Gastroenterol Hepatol (1996) 1.57
Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol (2001) 1.55
Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum Immunol (2005) 1.54
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther (2003) 1.52
The activity of myrosinase from broccoli (Brassica oleracea L. cv. Italica): influence of intrinsic and extrinsic factors. J Food Prot (2000) 1.52
Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma. Dig Liver Dis (2009) 1.50
Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver. J Hepatol (1998) 1.49
Lithium and venlafaxine interaction: a case of serotonin syndrome. J Clin Pharm Ther (2006) 1.48
Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. Scand J Gastroenterol (2003) 1.44
[The prevalence of anti-HCV positivity among blood donors in Asturias. A clinical-epidemiologic study]. Med Clin (Barc) (1994) 1.41
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer (2011) 1.41
The power of information and contraceptive choice in a family planning setting in Mexico. Sex Transm Infect (2000) 1.40
Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice. Rev Esp Enferm Dig (2004) 1.39
Early open mitral commissurotomy: long-term results. J Thorac Cardiovasc Surg (1993) 1.39
Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology (1998) 1.39
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology (1981) 1.38
[Coinfection with hepatitis G virus in chronic hepatitis C. Response to treatment with interferon alpha]. Med Clin (Barc) (2000) 1.38
[The accidental detection of anti-HCV positivity and monoclonal gammapathy]. Rev Clin Esp (1993) 1.38
Genomic and antigenomic chains of hepatitis C virus and hepatitis G virus in serum, liver and peripheral blood mononuclear cells. Rev Esp Enferm Dig (2002) 1.37
Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol (2000) 1.36
Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion (2001) 1.35
6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol (2000) 1.34
Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis (2005) 1.32
Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod (2003) 1.29
The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology (1998) 1.27
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. Aliment Pharmacol Ther (1997) 1.25
Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology (1993) 1.23
Prevalence of Coeliac disease in the general population of northern Spain. Strategies of serologic screening. Scand J Gastroenterol (2000) 1.23
Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients. Aliment Pharmacol Ther (1999) 1.21
Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) (1996) 1.19
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol (2010) 1.15
Spiral CT findings in active and remission phases in patients with Crohn disease. J Comput Assist Tomogr (2001) 1.14
Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol (1997) 1.13
Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Aliment Pharmacol Ther (2008) 1.12
Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther (2006) 1.11
Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology (1990) 1.10
Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut (2006) 1.09
Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest (1998) 1.09
Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology (1995) 1.08
Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res (1993) 1.08
Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J Clin Immunol (2001) 1.07
Usefulness of manometry to select patients with anal fissure for controlled anal dilatation. Rev Esp Enferm Dig (2010) 1.07
The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int (2008) 1.06
Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun (2009) 1.05
Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol (2001) 1.05
Longer-term clinical and economic benefits of offering acupuncture to patients with chronic low back pain assessed as suitable for primary care management. Complement Ther Med (1999) 1.04
Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol (2014) 1.04
The characteristics of epilepsy in a largely untreated population in rural Ecuador. J Neurol Neurosurg Psychiatry (1994) 1.03
Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol (1995) 1.02
S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol (2001) 1.01
Factors that impact health-related quality of life in adults with celiac disease: a multicenter study. World J Gastroenterol (2008) 1.00
Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol (1996) 0.99
Validation of a method to quantify chromium, cadmium, manganese, nickel and lead in human whole blood, urine, saliva and hair samples by electrothermal atomic absorption spectrometry. Anal Chim Acta (2009) 0.99
Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther (2005) 0.98
Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Hum Reprod (2001) 0.97
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther (2007) 0.97
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther (2006) 0.96
Trovafloxacin-induced acute hepatitis. Clin Infect Dis (2000) 0.96
Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin. Dig Liver Dis (2009) 0.94
Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci (2001) 0.94
Prevention, treatment, and social action: a strategy of intervention in a disadvantaged urban area. Am J Orthopsychiatry (1966) 0.94
Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa-2b. Gastroenterology (1993) 0.93
Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients. Reprod Biomed Online (2003) 0.93
Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol (2000) 0.93
Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. J Allergy Clin Immunol (2001) 0.92
Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases. Pharmacogenomics J (2013) 0.92
Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha. Aliment Pharmacol Ther (1998) 0.92
Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients. Aliment Pharmacol Ther (2008) 0.92
Human liver paraoxonase (PON1): subcellular distribution and characterization. J Biochem Mol Toxicol (1998) 0.91
Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma. J Clin Gastroenterol (1998) 0.90
Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. J Viral Hepat (2002) 0.90
Identification of calcium palmitate in gallstones by infra-red spectroscopy. Clin Chim Acta (1982) 0.90
Appreciation of indirect requests by left- and right-brain-damaged patients: the effects of verbal context and conventionality of wording. Brain Lang (1989) 0.90